Published trade mark details for 2632733

This information was published on 2026-09-11T10:41:21 for IP Right Registration Published.

Field Value
(210) 2632733 (IR 1905098)
(220) 03 Feb 2026
(511) (510) Class 44
Medical screening; medical testing services for diagnostic or treatment purposes; DNA screening for medical purposes.
(540) CANCERNEXT
(550) Word
(730) AMBRY GENETICS CORPORATION

 

Find out more about publications on the About page.